Live feed
Filing
SC 13D/A
SC 13D/A0001104659-22-076841·GYRE THERAPEUTICS, INC.
Schedule 13D ownership disclosure
CATALYST BIOSCIENCES INC
Security class unavailable · CUSIP: 14888D208
Event date: 2022-06-29
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,550,000
- Percent of class
- 4.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-22-076841
- Form type
- SC 13D/A
- Filer
- GYRE THERAPEUTICS, INC.
- CIK
- CIK 1124105
- Filed
- Jul 01, 2022
- Reporting period
- Jun 29, 2022
- Description
- Schedule 13D beneficial ownership